Clinical trial
Effect of Milnacipran Versus Gabapentin or Combination of Both in Fibromyalgia Syndrome
NCT05384210 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Milnacipran Versus Gabapentin or Combination of Both in Fibromyalgia Syndrome
- Lead sponsor
- Mansoura University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- November 30, 2023
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.